12.24
price down icon1.09%   -0.135
after-market 시간 외 거래: 12.10 -0.145 -1.18%
loading
전일 마감가:
$12.38
열려 있는:
$12.33
하루 거래량:
30,480
Relative Volume:
0.62
시가총액:
$49.52M
수익:
$147.75M
순이익/손실:
$-284.23M
주가수익비율:
-4.1792
EPS:
-2.93
순현금흐름:
$-317.54M
1주 성능:
+7.60%
1개월 성능:
+15.19%
6개월 성능:
+42.97%
1년 성능:
+31.31%
1일 변동 폭
Value
$12.06
$12.58
1주일 범위
Value
$11.02
$12.58
52주 변동 폭
Value
$4.50
$21.94

Fibrogen Inc Stock (FGEN) Company Profile

Name
명칭
Fibrogen Inc
Name
전화
415-978-1200
Name
주소
350 BAY STREET, SAN FRANCISCO, CA
Name
직원
225
Name
트위터
@FibroGenInc
Name
다음 수익 날짜
2025-03-17
Name
최신 SEC 제출 서류
Name
FGEN's Discussions on Twitter

FGEN을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
FGEN
Fibrogen Inc
12.24 50.06M 147.75M -284.23M -317.54M -2.93
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
381.87 96.56B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
449.58 60.08B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
555.51 61.15B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ARGX
Argen X Se Adr
711.09 44.66B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
328.71 36.23B 3.81B -644.79M -669.77M -6.24

Fibrogen Inc Stock (FGEN) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2023-08-08 다운그레이드 BofA Securities Neutral → Underperform
2023-06-26 다운그레이드 BofA Securities Buy → Neutral
2023-06-26 다운그레이드 Raymond James Outperform → Mkt Perform
2023-06-26 다운그레이드 Stifel Buy → Hold
2023-06-26 다운그레이드 William Blair Outperform → Mkt Perform
2023-06-02 업그레이드 Stifel Hold → Buy
2023-01-31 업그레이드 William Blair Mkt Perform → Outperform
2023-01-26 업그레이드 Raymond James Mkt Perform → Outperform
2023-01-05 업그레이드 BofA Securities Neutral → Buy
2021-09-22 다운그레이드 Goldman Neutral → Sell
2021-08-20 업그레이드 Raymond James Underperform → Mkt Perform
2021-07-16 다운그레이드 BofA Securities Buy → Neutral
2021-07-16 다운그레이드 Stifel Buy → Hold
2021-04-07 다운그레이드 H.C. Wainwright Buy → Neutral
2021-04-07 다운그레이드 Mizuho Buy → Neutral
2021-03-31 업그레이드 BofA Securities Neutral → Buy
2021-03-02 다운그레이드 Jefferies Buy → Hold
2021-02-01 개시 H.C. Wainwright Buy
2020-10-26 개시 Raymond James Underperform
2020-07-10 재개 Stifel Buy
2020-05-01 개시 Cowen Market Perform
2020-04-27 개시 BofA/Merrill Neutral
2019-05-29 재개 Goldman Neutral
2019-05-10 다운그레이드 William Blair Outperform → Mkt Perform
2019-04-12 개시 Piper Jaffray Neutral
2019-02-11 재개 Stifel Buy
2018-12-19 업그레이드 Citigroup Neutral → Buy
2017-08-08 재확인 Leerink Partners Outperform
2017-08-08 재확인 Stifel Buy
2017-07-21 다운그레이드 Goldman Buy → Neutral
2017-07-11 개시 Jefferies Buy
2016-02-11 업그레이드 Credit Suisse Neutral → Outperform
2016-01-21 개시 Credit Suisse Neutral
2015-12-04 개시 Citigroup Buy
2015-09-23 개시 Lake Street Hold
2015-07-29 개시 Citigroup Buy
2015-07-20 업그레이드 Goldman Neutral → Buy
2014-12-09 개시 Stifel Buy
모두보기

Fibrogen Inc 주식(FGEN)의 최신 뉴스

pulisher
11:58 AM

William Blair Remains a Hold on FibroGen (FGEN) - The Globe and Mail

11:58 AM
pulisher
07:51 AM

FibroGen stock advances as H.C. Wainwright reiterates Buy rating on FG-3246 progress - Investing.com

07:51 AM
pulisher
Sep 24, 2025

FGEN: HC Wainwright & Co. Reiterates 'Buy' Rating with $43 Targe - GuruFocus

Sep 24, 2025
pulisher
Sep 24, 2025

FibroGen (FGEN) Launches Phase 2 Trial for Antibody-Drug Conjuga - GuruFocus

Sep 24, 2025
pulisher
Sep 24, 2025

FibroGen initiates phase 2 trial of FG-3246 for prostate cancer - Investing.com Australia

Sep 24, 2025
pulisher
Sep 24, 2025

FibroGen Initiates Phase 2 Monotherapy Trial of FG-3246, a First-in-Class CD46 Targeting ADC, in Metastatic Castration-Resistant Prostate Cancer - The Manila Times

Sep 24, 2025
pulisher
Sep 24, 2025

FibroGen Initiates Phase 2 Trial for FG-3246 in Metastatic Castration-Resistant Prostate Cancer, Evaluating Companion PET Imaging Agent FG-3180 - Quiver Quantitative

Sep 24, 2025
pulisher
Sep 24, 2025

FibroGen Initiates Phase 2 Monotherapy Trial of FG-3246, a - GlobeNewswire

Sep 24, 2025
pulisher
Sep 24, 2025

First-in-Class CD46 Targeting ADC: FibroGen's FG-3246 Enters Phase 2 Trial for Advanced Prostate Cancer - Stock Titan

Sep 24, 2025
pulisher
Sep 22, 2025

Treasury Yields: Is FibroGen Inc stock a buy or sell2025 Trade Ideas & Reliable Momentum Entry Alerts - خودرو بانک

Sep 22, 2025
pulisher
Sep 22, 2025

Market Catalysts: Is FibroGen Inc vulnerable to short sellersVolume Spike & Free Safe Entry Trade Signal Reports - خودرو بانک

Sep 22, 2025
pulisher
Sep 21, 2025

Fed Watch: Why is FibroGen Inc stock going upJuly 2025 Price Swings & Low Drawdown Trading Strategies - khodrobank.com

Sep 21, 2025
pulisher
Sep 20, 2025

Aug Volume: Will FibroGen Inc stock benefit from M A2025 Historical Comparison & Capital Protection Trade Alerts - خودرو بانک

Sep 20, 2025
pulisher
Sep 20, 2025

What is FibroGen Incs revenue forecast2025 Trading Volume Trends & Weekly Watchlist of Top Performers - khodrobank.com

Sep 20, 2025
pulisher
Sep 19, 2025

Volatility Watch: Can FibroGen Inc sustain its profitabilityWall Street Watch & Smart Allocation Stock Tips - khodrobank.com

Sep 19, 2025
pulisher
Sep 19, 2025

Meme Stocks: Is FibroGen Inc stock a value trapBull Run & Breakout Confirmation Alerts - خودرو بانک

Sep 19, 2025
pulisher
Sep 19, 2025

Wall Street Zen Upgrades FibroGen (NASDAQ:FGEN) to "Hold" - MarketBeat

Sep 19, 2025
pulisher
Sep 19, 2025

Growth Value: Will FibroGen Inc benefit from rising consumer demandQuarterly Trade Review & Consistent Income Trade Recommendations - خودرو بانک

Sep 19, 2025
pulisher
Sep 19, 2025

FibroGen appoints David DeLucia CFO - MSN

Sep 19, 2025
pulisher
Sep 18, 2025

Aug Selloffs: Is FibroGen Inc. affected by consumer sentimentGap Up & Real-Time Volume Triggers - khodrobank.com

Sep 18, 2025
pulisher
Sep 18, 2025

FibroGen Sells Subsidiary to AstraZeneca for $220M - MSN

Sep 18, 2025
pulisher
Sep 17, 2025

FOMO Trade: What is OXLCGs valuation compared to sectorDay Trade & Daily Entry Point Trade Alerts - خودرو بانک

Sep 17, 2025
pulisher
Sep 16, 2025

China State Administration for Market Regulation approves sale of FibroGen China to AstraZeneca - MSN

Sep 16, 2025
pulisher
Sep 16, 2025

SEC Charges Public Company and Executive with Disclosure Fraud - The National Law Review

Sep 16, 2025
pulisher
Sep 16, 2025

Breakout Move: Is Spectral AI Inc Equity Warrant stock heavily shortedJuly 2025 Catalysts & Expert-Curated Trade Recommendations - khodrobank.com

Sep 16, 2025
pulisher
Sep 16, 2025

Fibrogen leads drug developer stock gains on China sale, FDA update - BioWorld MedTech

Sep 16, 2025
pulisher
Sep 15, 2025

S P Trends: Can FibroGen Inc sustain its profitabilityWeekly Risk Summary & AI Powered Buy/Sell Recommendations - خودرو بانک

Sep 15, 2025
pulisher
Sep 15, 2025

Downgrade Watch: What is the target price for FibroGen Inc stockWeekly Trade Recap & Proven Capital Preservation Methods - خودرو بانک

Sep 15, 2025
pulisher
Sep 15, 2025

Hedge Fund Moves: Can FibroGen Inc be the next market leaderJuly 2025 Chart Watch & Fast Momentum Entry Tips - خودرو بانک

Sep 15, 2025
pulisher
Sep 15, 2025

Will FibroGen Inc benefit from government policyQuarterly Market Review & Technical Entry and Exit Alerts - خودرو بانک

Sep 15, 2025
pulisher
Sep 15, 2025

Buyback Watch: What is the long term forecast for FibroGen Inc stockRecession Risk & Weekly High Return Stock Forecasts - خودرو بانک

Sep 15, 2025
pulisher
Sep 15, 2025

How to build a custom watchlist for FibroGen Inc.Earnings Summary Report & AI Driven Stock Movement Reports - newser.com

Sep 15, 2025
pulisher
Sep 15, 2025

Inflation Data: Is FibroGen Inc stock a value trap2025 Momentum Check & Safe Entry Point Identification - خودرو بانک

Sep 15, 2025
pulisher
Sep 15, 2025

Understanding FibroGen Inc.’s price movementMarket Activity Summary & Capital Efficiency Focused Strategies - newser.com

Sep 15, 2025
pulisher
Sep 15, 2025

Support Test: Can Polyrizon Ltd. outperform under higher oil pricesQuarterly Risk Review & Free Real-Time Volume Trigger Notifications - خودرو بانک

Sep 15, 2025
pulisher
Sep 15, 2025

Best data tools to analyze FibroGen Inc. stockPrice Action & Safe Investment Capital Preservation Plans - newser.com

Sep 15, 2025
pulisher
Sep 15, 2025

Predicting FibroGen Inc. trend using moving averagesEarnings Summary Report & Capital Efficient Trading Techniques - newser.com

Sep 15, 2025
pulisher
Sep 15, 2025

Live market analysis of FibroGen Inc.Earnings Growth Summary & Stock Portfolio Risk Control - newser.com

Sep 15, 2025
pulisher
Sep 14, 2025

Developing predictive dashboards with FibroGen Inc. dataJuly 2025 Update & Low Drawdown Trading Techniques - newser.com

Sep 14, 2025
pulisher
Sep 14, 2025

How to forecast FibroGen Inc. trends using time seriesPortfolio Update Summary & Real-Time Chart Pattern Alerts - newser.com

Sep 14, 2025
pulisher
Sep 14, 2025

Will FibroGen Inc. price bounce be sustainable2025 Breakouts & Breakdowns & Daily Profit Maximizing Trade Tips - newser.com

Sep 14, 2025
pulisher
Sep 14, 2025

Detecting support and resistance levels for FibroGen Inc.Gap Up & Weekly Return Optimization Plans - newser.com

Sep 14, 2025
pulisher
Sep 13, 2025

FRAUD AND MANIPULATION—N.D. Cal.: Former FibroGen CMO charged after allegedly reverse engineering drug results - VitalLaw.com

Sep 13, 2025
pulisher
Sep 13, 2025

FibroGen (NASDAQ:FGEN) Upgraded at Wall Street Zen - Defense World

Sep 13, 2025
pulisher
Sep 12, 2025

$1.25 million penalty for FibroGen over ‘false and misleading statements’ case - The Pharma Letter

Sep 12, 2025
pulisher
Sep 09, 2025

FibroGen at H.C. Wainwright: Strategic Moves and Future Prospects By Investing.com - Investing.com Nigeria

Sep 09, 2025
pulisher
Sep 09, 2025

FibroGen at H.C. Wainwright: Strategic Moves and Future Prospects - Investing.com

Sep 09, 2025
pulisher
Sep 09, 2025

Is FibroGen Inc. stock a buy or sell2025 Biggest Moves & Growth-Oriented Investment Plans - Lancaster City Council

Sep 09, 2025
pulisher
Sep 08, 2025

FibroGen To Pay SEC $1.25M Over Drug Mistatements - Law360

Sep 08, 2025
pulisher
Sep 08, 2025

Can FibroGen Inc. reach all time highs this yearJuly 2025 Review & Smart Money Movement Tracker - beatles.ru

Sep 08, 2025

Fibrogen Inc (FGEN) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading

Fibrogen Inc 주식 (FGEN) 내부자 거래

내부자 거래 관계 날짜 거래 비용 #주식 가치 ($) #주식 총계
Wettig Thane
CEO
Mar 24 '25
Buy
0.35
145,000
50,663
543,329
Schoeneck James A
Director
Mar 20 '25
Buy
0.35
250,000
88,000
323,722
Schoeneck James A
Director
Mar 21 '25
Buy
0.34
50,000
17,040
373,722
$34.90
price down icon 2.43%
$81.66
price down icon 2.97%
$28.84
price down icon 2.07%
$98.08
price down icon 1.67%
$135.59
price down icon 3.84%
biotechnology ONC
$328.71
price down icon 0.34%
자본화:     |  볼륨(24시간):